Wellkang® LLC
 
 
 
  • Introduction

  • List of Official Steps:
    1. Log-in Procedures
    2. Division Acceptance Criteria
    3. Reviewer Assignment
    4. FDA Requests for
      Additional Information

    5. Administrative Review
    6. Decision Letter Issued
  • 510(k) Status Program

  •  
     
    February 11, 2002:

    The FDA requires that all non-US medical device manufacturers wishing to market their products in the United States must have a local representative in the US, i.e. the “US Agent”.

    Wellkang LLC is your reliable “US Agent” in dealing with FDA.





        

     


      Step 2: Division Acceptance Criteria (Part B)

    If the recommendation to accept has concurrence, the 510(k) will be assigned to a division reviewer. In this case, you will not receive an acceptance letter.

    If the recommendation not to accept has concurrence, a Refuse to Accept letter, detailing the omissions and inadequacies, will be mailed to the submitter or applicant. The letter will specify what information must be submitted if the applicant wishes to pursue clearance for marketing.

    If you receive a Refuse to Accept letter, send FDA the required information or a letter requesting an extension of time to obtain the information requested to the DMC within 30 days. If neither is received within 30 days, the 510(k) may be deleted from the system. In this case another 510(k) will be required for you to pursue FDA marketing clearance.

    Click here to continue...
     

     
     
    | Home | Services | Our Clients | About Us | Online Shop | Contact Us | Partners & Links |

    Copyright© 2004 - 2006 Wellkang® LLC - Member of Wellkang® Group
    All Rights Reserved. Terms of Use, Copyright& Disclaimer.
    Some information at this site is obtained from websites & publications of FDA
    Last updated on
    Melbourne, Florida, USA